Financial Instruments - Schedule of available-for-Sale financial instruments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 210,491	$ 13,769
Unrealized Gain	0
Unrealized Losses	(2,930)	(4)
Fair Value	207,561	13,765
U.S treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	57,999	6,060
Unrealized Gain	0	0
Unrealized Losses	(313)	(3)
Fair Value	57,686	6,057
Corporate securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	152,492	7,709
Unrealized Gain	0	0
Unrealized Losses	(2,617)	(1)
Fair Value	149,875	$ 7,708
Total cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2,392
Unrealized Gain	6
Unrealized Losses	0
Fair Value	2,398
Total cash equivalents | U.S treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2,392
Unrealized Gain	6
Unrealized Losses	0
Fair Value	$ 2,398